Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane and coiled-coil domain-containing protein 5A (TMCO5A) is a protein encoded by the TMCO5A gene located on chromosome 15 in humans[7][8]. It is predicted to be a structural, membrane-associated protein with localization primarily in the endoplasmic reticulum and nuclear membranes[8], and is notably expressed at high levels in the cytoplasm of spermatids, suggesting a specialized role in testicular tissue[5]. While genetic associations link the gene to prostate cancer and spastic paraplegia 11, there is no direct evidence indicating TMCO5A is a common therapeutic target, nor are there any approved drugs or mechanisms of action described for this molecule[1]. Its molecular function appears related to protein binding and possible structural maintenance, and it is not currently classified within major drug target families such as ion channels, GPCRs, or receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane and coiled-coil domain-containing protein 5A (TMCO5A).